Skip to content

*Kappa-deleting recombination excision circles* (KRECs) and somatic hypermutation (SHM) in Down Syndrome B-lymphocytes.

*Kappa-deleting recombination excision circles* (KRECs) and somatic hypermutation (SHM) in Down Syndrome B-lymphocytes. - BKS-Down; blood

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34940
Enrollment
12
Registered
2010-05-12
Start date
2010-09-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down syndrome

Interventions

None listed

Sponsors

Jeroen Bosch Ziekenhuis
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Down syndrome, age >7 years

Exclusion criteria

Exclusion criteria: Infectious disease or treated for malignancy

Design outcomes

Primary

MeasureTime frame
Description of the replication history of DS-B-lymphocytes in relation to reference groups. This replication history will be presented in divisions per B-lymphocyte subpopulation. Somatic hypermutation will be presented as the percentage of mutated V*3-20-J* allels.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)